How Ph.D. was paid
$828,307 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Other | Total |
|---|---|---|---|---|
| Frank Bedu-Addo, Ph.D.Chief Executive Officer | $615,322 | $193,500 | $19,485 | $828,307 |
| Kirk Shepard, M.D.Chief Medical Officer | $463,500 | $193,500 | $20,318 | $677,318 |
| Stephan ToutainChief Operating Officer | $463,500 | $193,500 | $16,629 | $673,629 |
What changed and why
- $828K$828,307 was the CEO's 2025 total compensation, down from $2,263,569 in 2024.
- $615K$615,322 was the CEO's 2025 salary, alongside $193,500 in option awards.
- No discretionary annual cash bonuses were paid to named executive officers for 2025 performance.
- 55%2025 target bonuses were up to 55% for the CEO and 40% for each other named executive officer.
- Performance evaluation emphasized R&D, clinical, regulatory, financing, organizational, and shareholder-value milestones.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.